arrow
S

Shoaib Khan

Taif University
H指数:12
被引数:1,051

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Computer-aided development of novel thiazolidinone–thiazole derivatives: multidimensional structure–activity relationships revealed by quantum chemical analysis, molecular docking and biological investigation

计算机辅助新型噻唑烷酮-噻唑衍生物的开发:量子化学分析、分子对接和生物研究揭示的多维构效关系

2026-10-160
PRE
Pharmacophore-guided computational profiling of thiadiazole-based therapeutic addressing flap necrosis: Molecular simulation, DFT mapping, pharmacokinetic and kinetic evaluation

噻二唑基治疗药物靶向治疗瓣膜坏死的药效基指导计算分析:分子模拟、DFT映射、药代动力学和动力学评估

2026-08-010
PRE
Synthesis and molecular tailoring of thienopyrazone-derived oxadiazoles for diabetes: Kinetic evaluation, DFT studies and in silico modeling

噻吩吡嗪衍生物来源的噁二唑类化合物的合成与分子修饰用于糖尿病:动力学评价、DFT研究和计算机模拟

2026-07-090
PRE
Deciphering enzyme inhibition of thiazole assemblies for diabetes management via molecular docking, dynamic simulation, DFT and kinetic study: A computational therapeutic strategy

通过分子对接、动力学模拟、DFT和动力学研究解析噻唑类组装体的酶抑制作用以管理糖尿病:一种计算治疗策略

2026-04-150
PRE
Synthesis, structure-activity relationship and enzyme kinetics of triazole-appended oxadiazoles as dual inhibitors against α-amylase and α-glucosidase

三氮唑官能化的噁二唑类化合物作为α-淀粉酶和α-葡萄糖苷酶双抑制剂的合成、构效关系及酶动力学研究

2026-04-120
PRE
Synthesis, computational evaluation and pharmacological assessment of novel triazole–thiadiazole-based pyrrole derivatives as glycemic regulators in diabetes mellitus

合成、计算评价及药理学评估:以三唑–噻二唑为基团的吡咯衍生物作为糖尿病血糖调节剂

2026-03-120
PRE
Potent cholinesterase inhibitors for alzheimer's disease: synthesis, biological evaluation and computational analysis of novel oxadiazole analogues

阿尔茨海默病的高效胆碱酯酶抑制剂:新型噁二唑类似物的合成、生物评价和计算分析

2026-01-010
PRE